ArticleReproduction & fertility2025
Chromosomal miscarriage and pregnancy outcomes in recurrent pregnancy loss.
Article in Reproduction & fertility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Miscarriage and the Microbiome: Host Genetics, Immunity, and the Reproductive Tract Ecosystem.Genes · 2026Review
- PGT-A versus expectant management for fertile patients with recurrent pregnancy loss and prior aneuploidy: a dual-center, real-world study of 5-year cumulative pregnancy outcomes.Frontiers in endocrinology · 2026Observational
- Establishment and application of a prediction model for blastocyst formation rate and delivery outcome in human assisted reproductive technology.Reproduction & fertility · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: This prospective cohort study aimed to assess whether a history of embryonic chromosomal abnormality affects subsequent pregnancy outcomes in women with unexplained recurrent pregnancy loss. A total of 233 women with unexplained recurrent pregnancy loss who conceived naturally were included. Participants were categorized according to the chromosomal status of prior miscarriages. A multivariate logistic regression model was constructed to predict live birth based on these categories and observed pregnancy outcomes. Among the 233 included women, 171 (73.4%) had a live birth, while 62 (26.6%) experienced early pregnancy loss. Among women with one abnormal chromosomal miscarriage (n = 110), 94 (85.5%) had a live birth, accounting for 40.3% of the total cohort. In contrast, in the one normal chromosomal miscarriage group (n = 77), 47 (61.0%) achieved live birth, representing 20.2% of the total. The model identified a history of one chromosomally abnormal miscarriage (odds ratio = 3.88, 95% confidence interval: 1.87-8.06) and history of two chromosomally abnormal miscarriages (odds ratio = 8.93, 95% confidence interval: 1.07-74.55) as significant predictors of live birth. The predictive model achieved an area under the curve of 0.73 in the training dataset and 0.75 in the testing dataset. A history of embryonic chromosomal miscarriage may reflect improved pregnancy prospects and inform clinical counseling in unexplained recurrent pregnancy loss. Lay summary: Women with unexplained recurrent miscarriage often wonder whether their history will affect future natural pregnancies. Chromosomal abnormalities in embryos are a leading cause of miscarriage, but the impact of such a history on later outcomes has remained unclear. We studied 233 women with repeated unexplained losses and assessed their subsequent pregnancy results. Overall, 73.4% achieved a live birth, while 26.6% had another early miscarriage. Interestingly, among women who had one chromosomal abnormal miscarriage, 85.5% subsequently achieved a live birth. In contrast, the live birth rate was lower in the group who had a normal chromosomal miscarriage; only 61.0% went on to achieve a live birth. These results suggest that a history of abnormal chromosomal miscarriage may indicate better chances of future pregnancy and help guide clinical care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.